OptiBiotix Health (OPTI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

18.75p
   
  • Change Today:
      0.63p
  • 52 Week High: 39.00
  • 52 Week Low: 6.00
  • Currency: UK Pounds
  • Shares Issued: 97.94m
  • Volume: 116,607
  • Market Cap: £18.36m

Deal with Barclays    Trade now with Barclays Stockbrokers

OptiBiotix launches two new products at Geneva trade show

By Josh White

Date: Tuesday 16 May 2017

LONDON (ShareCast) - (ShareCast News) - Life sciences business OptiBiotix Health announced the successful launch of its SlimBiome and LPLDL products at the Vitafoods Europe trade show in Geneva from the 9-11 of May on Tuesday.
The AIM-traded company said the event provided the opportunity to connect with 16,500 industry "decision makers" from the supplements, nutraceutical, functional food and beverage industries.

Its board said the event is viewed as "one of the world's leading" trade fairs for the food and drinks industry.

OptiBiotix said it launched the first of its range of heart health products containing LPLDL called CholBiome and CardioBiome, and its SlimBiome weight management technology.

Both product types were exhibited in the 'New Products Zone' and at Sacco's and Nutrilinea's stands.

Sacco and Nutrilinea are OptiBiotix's European manufacturing and formulation partners and reportedly have an extensive European network to "maximise the commercial opportunity" provided by the products.

Both LPLDL and SlimBiome were extremely well received, the OptiBiotix board said, with high interest in the distribution and sale of the products from partners across Europe, Japan, India, Asia, Australia and the US.

"We are extremely pleased with the very high level of interest from both national and multinational companies interested in selling our products," said CEO Stephen O'Hara.

"This has already resulted in some companies sending through draft contracts."

O'Hara said the company anticipated that the interest would start to generate revenues from both ingredient supply, and as a component in "high value" white label and branded formulations and presentations, across multiple territories.

"We are at the start of the commercialisation process but are really excited at the high level of interest in our products.

"We look forward to building commercial partnerships, market presence, and multiple revenue streams in both consumer health and pharmaceutical markets around the world."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OPTI Market Data

Currency UK Pounds
Share Price 18.75p
Change Today 0.63p
% Change 3.45 %
52 Week High 39.00
52 Week Low 6.00
Volume 116,607
Shares Issued 97.94m
Market Cap £18.36m

OPTI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.56% above the market average61.56% above the market average61.56% above the market average61.56% above the market average61.56% above the market average
92.16% above the sector average92.16% above the sector average92.16% above the sector average92.16% above the sector average92.16% above the sector average
Price Trend
13.84% below the market average13.84% below the market average13.84% below the market average13.84% below the market average13.84% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth
96.85% below the market average96.85% below the market average96.85% below the market average96.85% below the market average96.85% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

OPTI Dividends

No dividends found

Trades for 28-May-2024

Time Volume / Share Price
16:13 8,000 @ 18.82p
15:54 9,367 @ 18.82p
15:49 315 @ 18.37p
14:29 2,564 @ 18.37p
13:06 7,515 @ 18.90p

OPTI Key Personnel

CEO Stephen O'Hara
Finance Director Graham Myers

Top of Page